Last reviewed · How we verify
MRXXX and MR1XXX — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
MRXXX and MR1XXX (MRXXX and MR1XXX) — Mundipharma Research Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MRXXX and MR1XXX TARGET | MRXXX and MR1XXX | Mundipharma Research Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MRXXX and MR1XXX CI watch — RSS
- MRXXX and MR1XXX CI watch — Atom
- MRXXX and MR1XXX CI watch — JSON
- MRXXX and MR1XXX alone — RSS
Cite this brief
Drug Landscape (2026). MRXXX and MR1XXX — Competitive Intelligence Brief. https://druglandscape.com/ci/mrxxx-and-mr1xxx. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab